Amisulpride

Active ingredient description

Amisulpride is a neuroleptic. Amisulpride binds selectively with a high affinity to human dopaminergic D2/D3 receptor subtypes whereas it is devoid of affinity for D1, D4 and D5 receptor subtypes.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
N05AL05
Amisulpride
N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AL Benzamides
Discover more medicines within N05AL05

Medicines

Amisulpride is the active ingredient of these drugs:

Drug
Countries
AKTIPROL

Cyprus Lithuania Netherlands

AMIPRIDE

Australia Tunisia

AMIPRYD

Poland

AMISAN

Lithuania Poland

AMSULGEN

Poland

ARACALM

Spain

BARHEMSYS

United States

GEALEVIDE

Italy

SOCIAN

Brazil

SOLARID

Tunisia

SOLIAN

Australia Austria Cyprus France Germany

SULAMID

Cyprus

SULPRIX

Australia New Zealand

SYMAMIS

Poland

ZOFRID

Tunisia

ZOLEN

Tunisia

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
SOLIAN Tablets
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

8110R61I4U - AMISULPRIDE

CAS registry number

71675-85-9 - amisulpride

SNOMED-CT

391761004 - Amisulpride (substance)

Next: Usage